News

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...
An Alabama family has filed a high-profile lawsuit in Shelby County Circuit Court, alleging that a life-altering medical failure led to a missed diagnosis of advanced, incurable colon cancer. The ...
Zacks Investment Research on MSN4d

Tempus AI Taps Growing ICI Market With New xM Assay

Tempus AI, Inc. TEM recently introduced xM for treatment response monitoring (TRM), a liquid biopsy assay. It is designed to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in ...